The Indian patent office granted 677 Patents for the month of March, 2014. The Top three consisted of Qualcomm Incorporated,GM Global Technology Operations Inc and Council of Scientific and Industrial Research, with a count of 42, 18 and 18 patents respectively. The table below shows the top ten
Patent Grant for the Month of March Read More »
The License agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare over a drug Dolutegravir (DTG) has brought new hope in the field of medicine. This New Drug Application (NDA) follows the approval of dolutegravir by the US Food and Drug Administration (FDA) in August 2013 under the brand name
Licensing Agreement to bring-in easy access to Dolutegravir (DTG). Read More »
The most famous drug for diabetes, Galvus also known as Vildagliptin is under patent litigation. Swiss drug maker Novartis has filed an infringement proceeding against Biocon, the Bangalore-based Company and Asia\’s largest insulin maker on Galvus or Vildagliptin, a DPP4 inhibitor class of drugs used to treat type-2 diabetes. Novartis filed the case on 27
Patent suit against Biocon- Keeping Galvus in check… Read More »
The European Patent Office (EPO), revealed the statistics for the global company that has filed patents in Europe. EPO says that Philips filed the third largest number of patent applications in 2013 with 59% increase compare to last year. The company has 64,000 patent rights, 93,000 design rights, 46,000 trademarks and 4,700 domain names. Other
Global Patent Trends Read More »
Marvell Technology Group Limited, the leading producer of Storage, communication products is entangled in a major patent Litigation case against a private Research University, Carnegie Mellon University (CMU). The federal court ordered Marvell to pay $1.5 Billion as enhanced penalties for deliberately infringing Carnegie’s Intellectual Property, the third largest ever in a patent case at
Patent Litigation Jackpot: Read More »
Hyderabad based-Natco Pharma has won a patent battle against Israeli drug giant Teva Pharmaceuticals, over Copaxone, a drug used to treat multiple sclerosis. Natco markets Copaxone (Glatiramer Acetate) used in the treatment of relapsing-remitting multiple sclerosis — in the US market. The drug\’s patent to Teva is set to expire in May. Teva appealed The
NATCO Pharma Wins Patent War against Teva Pharmaceuticals. Read More »
Intellectual Property (IP) is an invaluable asset that contributes to the success and growth of any business. Valuation of intellectual property (IP) based asset is of high importance for any organization that places high emphasis in protecting and managing its IP. This is because unless you are aware of the value of your IP, it
Why Value Intellectual Property? Read More »
Recently, the Canadian government tabled five intellectual property treaties in the House of Commons. These treaties are The Madrid Protocol The Hague Agreement The Singapore Treaty The Nice Agreement & The Patent Law Treaty. The Madrid Protocol enables trade-mark owners to obtain registered trade-mark protection more easily. They can get this facility by filing of
Canada to Finally Update Intellectual Property Legislation Read More »
The Korean Intellectual Property Office (KIPO) has recently proposed a number of significant changes. The Amended Trademark Act will take effect on July 1 2015. The table below gives a brief detail about those few amended acts. Current Law New law Article 2(1)(vi), the actions that may be considered use of a Trademark under the
KIPO proposes Amendments to Trademark Act Read More »
In continuation with our previous blog King.com, the makers of the wildly popular “match 3” online game Candy Crush Saga, have withdrawn their trademark application on game use of the word “Candy” following a series of protracted controversies in advance of their upcoming initial public offering.
© 2024 ipMetrix. All Rights Reserved
